Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
Journal Title
Loading...
Issue Date
2005
Authors
Medical Center Staff
Publisher
Stony Brook Medicine, Stony Brook University
Keywords
Abstract
Description
DOI
Collections
Content Designation
Archived web content